Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

Ryan removes indicted GOP lawmaker from House Energy and Commerce Committee

House Speaker Paul RyanPaul Davis RyanTrump quietly rolled back programs to detect, combat weapons of mass destruction: report Ocasio-Cortez top aide emerges as lightning rod amid Democratic feud Juan Williams: GOP in a panic over Mueller MORE (R-Wis.) on Wednesday said Rep. Chris CollinsChristopher (Chris) Carl CollinsMichael Caputo eyes congressional bid House ethics panel renews probes into three GOP lawmakers The Hill's Morning Report - Barr stiff-arms House following Senate grilling MORE (R-N.Y.) has been removed from his post on the House Energy and Commerce Committee as a result of the lawmaker's indictment on insider trading charges.

Collins was arrested and charged with federal securities fraud related to an Australian pharmaceutical company of which he had been the largest shareholder.

ADVERTISEMENT

“While his guilt or innocence is a question for the courts to settle, the allegations against Rep. Collins demand a prompt and thorough investigation by the House Ethics Committee," Ryan said in a statement. "Insider trading is a clear violation of the public trust. Until this matter is settled, Rep. Collins will no longer be serving on the House Energy and Commerce Committee.”

House Majority Whip Steve ScaliseStephen (Steve) Joseph ScaliseThe Memo: Fears of violence grow amid Trump race storm Democrats call for increased security after 'send her back' chants Democratic strategist on Trump tweets: 'He's feeding this fear and hate' MORE (R-La.) backs the Speaker’s decision to remove Collins from the committee, a Scalise spokesman told The Hill.

According to the indictment, Collins's son, Cameron Collins, and Stephen Zarsky, the father of Cameron Collins's fiancée, are also being charged.

The Buffalo-area congressman turned himself in to the FBI and is slated to appear in court later in the day, NBC News reported.

An Office of Congressional Ethics report released in 2017 stated there is “substantial reason to believe” he shared nonpublic information about the Australian pharmaceutical company.